You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ROIV Sale Disclosure
Gold Daniel Allen · SEC Form 4 · Filed Jun 30, 2026
Sale
Calculated transaction value
$6.89M
Gold Daniel Allen Director
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
ROIV daily price context
Close on/before transaction
$34.73
Jun 29, 2026
First close after public filing
$35.03
Jul 1, 2026
30-day return after filing
-1.46%
Through Jul 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 200,000 shares @ $34.44
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-291163
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$49.35M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV | Sale | Jun 30, 2026 | $436.77K |
| Roivant Sciences Ltd. ROIV Current | Sale | Jun 29, 2026 | $6.89M |
| Roivant Sciences Ltd. ROIV | Sale | Jun 29, 2026 | $20.75M |
| Roivant Sciences Ltd. ROIV | Sale | Jun 26, 2026 | $10.2M |
| Roivant Sciences Ltd. ROIV | Sale | Jun 26, 2026 | $11.07M |